October 18, 2019 Texas HIV Medication Advisory Committee
»
1. Call to Order and Welcome – Dr. Natalie Vanek, M.D., Acting Committee Chair
1. Call to Order and Welcome – Dr. Natalie Vanek, M.D., Acting Committee Chair
»
2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
2. Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC
»
4. Member Recognition – Felipe Rocha, MSSW Director TB/HIV/STD Section and Dr. Natalie Vanek, M.D., Acting Committee Chair
4. Member Recognition – Felipe Rocha, MSSW Director TB/HIV/STD Section and Dr. Natalie Vanek, M.D., Acting Committee Chair
»
5. Adoption of Election Procedures and Election of Presiding Officers (Vote Required) – John Chacon, Advisory Committee Coordination Office, HHSC
5. Adoption of Election Procedures and Election of Presiding Officers (Vote Required) – John Chacon, Advisory Committee Coordination Office, HHSC
»
6. Review and Approval of July 19, 2019, Meeting Minutes (Vote Required) - Sallie Allen, Advisory Committee Coordination Office, HHSC
6. Review and Approval of July 19, 2019, Meeting Minutes (Vote Required) - Sallie Allen, Advisory Committee Coordination Office, HHSC
»
Items 7 & 8 » - 7. Commissioners and Legislative Updates – Imelda Garcia, Associate Commissioner, DSHS 8. Budget Update – Felipe Rocha, MSSW Director TB/HIV/STD Section
Items 7 & 8 »
7. Commissioners and Legislative Updates – Imelda Garcia, Associate Commissioner, DSHS 8. Budget Update – Felipe Rocha, MSSW Director TB/HIV/STD Section
»
9. Texas HIV Medication Program (THMP) Update – Rachel Sanor, THMP Manager
9. Texas HIV Medication Program (THMP) Update – Rachel Sanor, THMP Manager
»
10. Presentation on Livalo and Zypitamag prescribing information (Part 1 of 2) » - a. Kowa Pharmaceuticals: Livalo b. Medicure: Zypitamag
10. Presentation on Livalo and Zypitamag prescribing information (Part 1 of 2) »
a. Kowa Pharmaceuticals: Livalo b. Medicure: Zypitamag
»
11. Sub-Committee Reports » - a. Governance/Data – Nancy Miertschi b. Eligibility – Frank Rosas c. Formulary – Dr. Natalie Vanek, M.D.
11. Sub-Committee Reports »
a. Governance/Data – Nancy Miertschi b. Eligibility – Frank Rosas
c. Formulary – Dr. Natalie Vanek, M.D.
»
10. Presentation on Livalo and Zypitamag prescribing information (Part 2 of 2) » - a. Kowa Pharmaceuticals: Livalo
b. Medicure: Zypitamag a. Kowa Pharmaceuticals: Livalo b. Medicure: Zypitamag
10. Presentation on Livalo and Zypitamag prescribing information (Part 2 of 2) »
a. Kowa Pharmaceuticals: Livalob. Medicure: Zypitamag
a. Kowa Pharmaceuticals: Livalo
b. Medicure: Zypitamag
»
12. Medication Advisory Committee (MAC) to vote on addition of the following medications to THMP formulary (Vote Required) » - a. Livalo b. Zypitamag
12. Medication Advisory Committee (MAC) to vote on addition of the following medications to THMP formulary (Vote Required) »
a. Livalo b. Zypitamag
»
13. MAC to vote on addition of the top ten non-HIV medications to THMP formulary (Vote Required) » - a. Lisinopril b. Gabapentin c. Metoprolol tartrate d. Duloxetine e. Sertraline f. Amlodipine g. Atorvastatin h. Trazodone i. HCTZ j. Metformin
13. MAC to vote on addition of the top ten non-HIV medications to THMP formulary (Vote Required) »
a. Lisinopril b. Gabapentin
c. Metoprolol tartrate
d. Duloxetine
e. Sertraline
f. Amlodipine
g. Atorvastatin
h. Trazodone
i. HCTZ
j. Metformin
»
Items 15 & 16 » - 15. Action items and agenda topics for next scheduled meeting January 17, 2020 – Dr. Natalie Vanek, M.D., Acting Committee Chair 16. Adjourn – Dr. Natalie Vanek, M.D., Acting Committee Chair
Items 15 & 16 »
15. Action items and agenda topics for next scheduled meeting January 17, 2020 – Dr. Natalie Vanek, M.D., Acting Committee Chair 16. Adjourn – Dr. Natalie Vanek, M.D., Acting Committee Chair
